Publication | Closed Access

The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments

NanoparticlesNanomedicineBevacizumab ActivityEngineeringOphthalmologyTherapeutic NanomaterialsMedicinePharmaceutical NanotechnologyVascular BiologyNano-drug DeliveryTumor TargetingPharmacologyProtective EffectPlga Nanoparticles